SANOFINSESanofi India Limited· PharmaceuticalsMediumNeutral
Announced Thu, 30 Apr · 16:27 IST

Sanofi India appoints Rahul Bhatnagar as Board Chairman

Management Changes View source PDF

SANOFI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.0%1-day move
₹3405.00
prior close
₹3405.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.3+0.6+1.0+1.0+0.0-0.2-0.4-2.1-3.9-4.6-6.6-6.5+1.6
Up moveDown movePending
AI summary

Sanofi India appointed Rahul Bhatnagar as Chairman of its Board effective April 30, 2026. Bhatnagar, an existing director since 2020 and a Chartered Accountant with a Wharton MBA, succeeds Aditya Narayan who completed a decade-long tenure. He also serves on boards of Whirlpool India, TBO TEK, Tasty Bite, and Rossell India. Independent Director Usha Thorat's tenure ended April 29, 2026.

Likely market impact

Smooth internal leadership transition. Continuity expected as Bhatnagar was already on the board; no material disruption likely.